Bruna M. R. de Andrade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bruna M. R. de Andrade has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Enaldo Vieira de Melo
Department of Medicine, Federal University of Sergipe (UFS), Aracaju 49100-000, Brazil
2 shared publications - Manuel Herminio Aguiar-Oliveira
Division of Endocrinology, Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Brazil
2 shared publications - Alaíde H. A. Oliveira
Univ Fed Sergipe, Div Odontol, Aracaju, SE, Brazil
1 shared publication Alaíde H.A. Oliveira
Department of Dentistry, Federal University of Sergipe, Aracaju, Sergipe, Brazil
1 shared publication- Anita H. O. Souza
Univ Fed Sergipe, Div Endocrinol, Programa Posgrad Ciencias Saude, Aracaju, SE, Brazil
1 shared publication Anita H.O. Souza
Division of Endocrinology, Department of Medicine, Federal University of Sergipe, Aracaju, Sergipe, Brazil
1 shared publication
Latest Publications
- Open Access
- 18 January 2023
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 67 (2) , 189-196
Predictive factors for the diagnosis of permanent congenital hypothyroidism and its temporal changes in Sergipe, Brazil – A real-life retrospective study
Objectives: Congenital hypothyroidism (CH) can be permanent (PCH) or transient (TCH). While the importance of thyroxine in myelination of the brain is undisputed, the benefits to neurodevelopmental outcomes of TCH treatment are controversial. Our objectives were to determine predictive factors for PCH and verify its prevalence changes over time. Subjects and methods: A total of 165 children were evaluated at 3 years of age to verify the diagnosis of PCH. 130 were submitted to a two-step cluster analysis, with [...] ABSTRACT Objectives: Congenital hypothyroidism (CH) can be permanent (PCH) or transient (TCH). While the importance of thyroxine in myelination of the brain is undisputed, the benefits to neurodevelopmental outcomes of TCH treatment are controversial. Our objectives were to determine predictive factors for PCH and verify its prevalence changes over time. Subjects and methods: A total of 165 children were evaluated at 3 years of age to verify the diagnosis of PCH. 130 were submitted to a two-step cluster analysis, with
- 18 January 2023
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 67 (2) , 189-196
Open AccessPredictive factors for the diagnosis of permanent congenital hypothyroidism and its temporal changes in Sergipe, Brazil – A real-life retrospective study
Objectives: Congenital hypothyroidism (CH) can be permanent (PCH) or transient (TCH). While the importance of thyroxine in myelination of the brain is undisputed, the benefits to neurodevelopmental outcomes of TCH treatment are controversial. Our objectives were to determine predictive factors for PCH and verify its prevalence changes over time. Subjects and methods: A total of 165 children were evaluated at 3 years of age to verify the diagnosis of PCH. 130 were submitted to a two-step cluster analysis, with [...] ABSTRACT Objectives: Congenital hypothyroidism (CH) can be permanent (PCH) or transient (TCH). While the importance of thyroxine in myelination of the brain is undisputed, the benefits to neurodevelopmental outcomes of TCH treatment are controversial. Our objectives were to determine predictive factors for PCH and verify its prevalence changes over time. Subjects and methods: A total of 165 children were evaluated at 3 years of age to verify the diagnosis of PCH. 130 were submitted to a two-step cluster analysis, with
- Open Access
- 23 March 2022
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 66 (2) , 198-205
Art and science: impact of semioccluded vocal tract exercises and choral singing on quality of life in subjects with congenital GH deficiency
Objectives: Currently, not much is known about the interactions between voice and growth hormone (GH). We have described large kindred with isolated GH deficiency (IGHD) due to a GHRH receptor mutation, resulting in severe short stature and high-pitched voice. These IGHD individuals have little interest in GH treatment, as they consider themselves “short long-lived people”, rather than patients. Interestingly, they report normal general quality of life, but they rate their Voice-Related Quality of Life (V-RQOL) as low. Here, we [...] ABSTRACT Objectives: Currently, not much is known about the interactions between voice and growth hormone (GH). We have described large kindred with isolated GH deficiency (IGHD) due to a GHRH receptor mutation, resulting in severe short stature and high-pitched voice. These IGHD individuals have little interest in GH treatment, as they consider themselves “short long-lived people”, rather than patients. Interestingly, they report normal general quality of life, but they rate their Voice-Related Quality of Life (V-RQOL) as low. Here, we
- 23 March 2022
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 66 (2) , 198-205
Open AccessArt and science: impact of semioccluded vocal tract exercises and choral singing on quality of life in subjects with congenital GH deficiency
Objectives: Currently, not much is known about the interactions between voice and growth hormone (GH). We have described large kindred with isolated GH deficiency (IGHD) due to a GHRH receptor mutation, resulting in severe short stature and high-pitched voice. These IGHD individuals have little interest in GH treatment, as they consider themselves “short long-lived people”, rather than patients. Interestingly, they report normal general quality of life, but they rate their Voice-Related Quality of Life (V-RQOL) as low. Here, we [...] ABSTRACT Objectives: Currently, not much is known about the interactions between voice and growth hormone (GH). We have described large kindred with isolated GH deficiency (IGHD) due to a GHRH receptor mutation, resulting in severe short stature and high-pitched voice. These IGHD individuals have little interest in GH treatment, as they consider themselves “short long-lived people”, rather than patients. Interestingly, they report normal general quality of life, but they rate their Voice-Related Quality of Life (V-RQOL) as low. Here, we
- 1 May 2016
- Published by Elsevier in Journal of Voice
- Vol. 30 (3) , 281-286
Voice Formants in Individuals With Congenital, Isolated, Lifetime Growth Hormone Deficiency
- 1 May 2016
- Published by Elsevier in Journal of Voice
- Vol. 30 (3) , 281-286
Voice Formants in Individuals With Congenital, Isolated, Lifetime Growth Hormone Deficiency